JP2021500055A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021500055A5 JP2021500055A5 JP2020523378A JP2020523378A JP2021500055A5 JP 2021500055 A5 JP2021500055 A5 JP 2021500055A5 JP 2020523378 A JP2020523378 A JP 2020523378A JP 2020523378 A JP2020523378 A JP 2020523378A JP 2021500055 A5 JP2021500055 A5 JP 2021500055A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cell
- lymphoma
- antibody
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023124386A JP2023139267A (ja) | 2017-10-27 | 2023-07-31 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
| JP2024173232A JP2024177330A (ja) | 2017-10-27 | 2024-10-02 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762577922P | 2017-10-27 | 2017-10-27 | |
| US62/577,922 | 2017-10-27 | ||
| PCT/IB2018/058013 WO2019082020A1 (en) | 2017-10-27 | 2018-10-16 | ANTIBODIES AND CONJUGATES CD123-SPECIFIC ANTIBODIES AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023124386A Division JP2023139267A (ja) | 2017-10-27 | 2023-07-31 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021500055A JP2021500055A (ja) | 2021-01-07 |
| JP2021500055A5 true JP2021500055A5 (https=) | 2021-11-25 |
| JP7324749B2 JP7324749B2 (ja) | 2023-08-10 |
Family
ID=64109968
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523378A Active JP7324749B2 (ja) | 2017-10-27 | 2018-10-16 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
| JP2023124386A Pending JP2023139267A (ja) | 2017-10-27 | 2023-07-31 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
| JP2024173232A Pending JP2024177330A (ja) | 2017-10-27 | 2024-10-02 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023124386A Pending JP2023139267A (ja) | 2017-10-27 | 2023-07-31 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
| JP2024173232A Pending JP2024177330A (ja) | 2017-10-27 | 2024-10-02 | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US11613581B2 (https=) |
| EP (1) | EP3700929A1 (https=) |
| JP (3) | JP7324749B2 (https=) |
| KR (1) | KR102363746B1 (https=) |
| CN (2) | CN111556876B (https=) |
| AU (1) | AU2018357221B2 (https=) |
| BR (1) | BR112020008127A2 (https=) |
| CA (2) | CA3079788C (https=) |
| CO (1) | CO2020005347A2 (https=) |
| IL (1) | IL274095B2 (https=) |
| MX (1) | MX2020004381A (https=) |
| PE (1) | PE20201255A1 (https=) |
| PH (1) | PH12020550596A1 (https=) |
| SA (1) | SA520411849B1 (https=) |
| SG (1) | SG11202003246WA (https=) |
| TW (2) | TWI718427B (https=) |
| WO (1) | WO2019082020A1 (https=) |
| ZA (1) | ZA202002207B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3027224B1 (en) * | 2013-07-31 | 2020-06-03 | Rinat Neuroscience Corp. | Engineered polypeptide conjugates using transglutaminase |
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| WO2019057772A1 (en) | 2017-09-19 | 2019-03-28 | Paul Scherrer Institut | METHOD FOR CONJUGATING TRANSGLUTAMINASE AND BINDING SEQUENCE |
| JP7324749B2 (ja) | 2017-10-27 | 2023-08-10 | ファイザー・インク | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
| SE544015C2 (en) * | 2019-06-18 | 2021-11-02 | Tx Medic Ab | Allogenic car-t cell therapy |
| US20230095053A1 (en) * | 2020-03-03 | 2023-03-30 | Sutro Biopharma, Inc. | Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use |
| CN113563470B (zh) * | 2020-04-29 | 2023-02-10 | 广州昂科免疫生物技术有限公司 | 结合tigit抗原的抗体及其制备方法与应用 |
| WO2021234593A1 (en) * | 2020-05-20 | 2021-11-25 | Janssen Biotech, Inc. | Methods for site specific conjugation of proteins containing glycosylated fc domains |
| CA3196218A1 (en) | 2020-10-25 | 2022-04-28 | Philipp SPYCHER | Means and methods for producing antibody-linker conjugates |
| WO2022248835A1 (en) * | 2021-05-26 | 2022-12-01 | Oxford Biotherapeutics Ltd | Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor |
| CN116018351A (zh) * | 2021-08-16 | 2023-04-25 | 上海优替济生生物医药有限公司 | 靶向cd123的抗体、嵌合抗原受体及其用途 |
| CN118159298A (zh) * | 2021-10-25 | 2024-06-07 | 阿拉里斯生物技术股份公司 | 生产抗体-接头偶联物的方法 |
| WO2024123765A1 (en) * | 2022-12-08 | 2024-06-13 | Immunogen, Inc. | Therapeutic combinations comprising anti-cd123 antibody-drug conjugates and anti-cd47 antibodies |
| WO2025227361A1 (en) * | 2024-04-30 | 2025-11-06 | Wuxi Xdc (Shanghai) Co., Ltd. | Process for preparing a composition of antibody-drug conjugates (adcs) with high d4 content |
| CN118416247A (zh) * | 2024-04-30 | 2024-08-02 | 上海药明合联生物技术有限公司 | 用于制备具有高d4含量的抗体-药物缀合物（adc）组合物的方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5663149A (en) | 1994-12-13 | 1997-09-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| EP1158997A2 (en) | 1999-03-09 | 2001-12-05 | University Of Southern California | Method of promoting myocyte proliferation and myocardial tissue repair |
| WO2008127735A1 (en) | 2007-04-13 | 2008-10-23 | Stemline Therapeutics, Inc. | Il3ralpha antibody conjugates and uses thereof |
| US8492119B2 (en) * | 2009-04-27 | 2013-07-23 | Kyowa Hakko Kirin Co., Ltd | Antibody to human IL-3 receptor alpha chain |
| US9676871B2 (en) * | 2010-11-05 | 2017-06-13 | Pfizer Inc. | Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
| KR101970025B1 (ko) | 2011-04-20 | 2019-04-17 | 메디뮨 엘엘씨 | Ｂ7-ｈ1 및 ｐｄ-1과 결합하는 항체 및 다른 분자들 |
| MY168297A (en) | 2011-11-17 | 2018-10-23 | Pfizer | Cytotoxic Peptides and Antibody Drug Conjugates Thereof |
| EP3027224B1 (en) | 2013-07-31 | 2020-06-03 | Rinat Neuroscience Corp. | Engineered polypeptide conjugates using transglutaminase |
| CN106459055B (zh) | 2014-01-27 | 2019-11-01 | 辉瑞大药厂 | 双功能细胞毒类药剂 |
| SI3134127T1 (sl) | 2014-04-25 | 2020-06-30 | Rinat Neuroscience Corp. | Konjugati zdravil s protitelesi z visoko stopnjo zdravila |
| JO3568B1 (ar) * | 2014-09-05 | 2020-07-05 | Janssen Pharmaceutica Nv | عوامل ربط cd123 واستخداماتها |
| CR20170383A (es) * | 2015-01-23 | 2017-11-22 | Sanofi Sa | Anticuerpos anti-cd3, anticuerpos anti-cd-123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123 |
| TW201709932A (zh) | 2015-06-12 | 2017-03-16 | 西雅圖遺傳學公司 | Ｃｄ１２３抗體及其共軛物 |
| JP6768011B2 (ja) * | 2015-06-23 | 2020-10-14 | バイエル ファーマ アクチエンゲゼルシャフト | キネシンスピンドルタンパク質（ｋｓｐ）阻害剤の抗ｃｄ１２３抗体との抗体薬物複合体 |
| ES2887273T3 (es) * | 2015-06-29 | 2021-12-22 | Immunogen Inc | Anticuerpos anti-CD123 y conjugados y derivados de los mismos |
| WO2019018525A1 (en) * | 2017-07-20 | 2019-01-24 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | CHIMERIC ANTIGENIC RECEPTORS BINDING TO CD123 |
| JP7324749B2 (ja) | 2017-10-27 | 2023-08-10 | ファイザー・インク | Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用 |
-
2018
- 2018-10-16 JP JP2020523378A patent/JP7324749B2/ja active Active
- 2018-10-16 AU AU2018357221A patent/AU2018357221B2/en active Active
- 2018-10-16 IL IL274095A patent/IL274095B2/en unknown
- 2018-10-16 WO PCT/IB2018/058013 patent/WO2019082020A1/en not_active Ceased
- 2018-10-16 EP EP18797140.3A patent/EP3700929A1/en active Pending
- 2018-10-16 US US16/758,124 patent/US11613581B2/en active Active
- 2018-10-16 CA CA3079788A patent/CA3079788C/en active Active
- 2018-10-16 SG SG11202003246WA patent/SG11202003246WA/en unknown
- 2018-10-16 MX MX2020004381A patent/MX2020004381A/es unknown
- 2018-10-16 CA CA3205442A patent/CA3205442A1/en active Pending
- 2018-10-16 CN CN201880069901.2A patent/CN111556876B/zh active Active
- 2018-10-16 PE PE2020000682A patent/PE20201255A1/es unknown
- 2018-10-16 KR KR1020207014653A patent/KR102363746B1/ko active Active
- 2018-10-16 BR BR112020008127-2A patent/BR112020008127A2/pt unknown
- 2018-10-16 CN CN202411219753.1A patent/CN119119272A/zh active Pending
- 2018-10-24 TW TW107137519A patent/TWI718427B/zh active
- 2018-10-24 TW TW110103347A patent/TWI793513B/zh active
-
2020
- 2020-04-27 SA SA520411849A patent/SA520411849B1/ar unknown
- 2020-04-28 CO CONC2020/0005347A patent/CO2020005347A2/es unknown
- 2020-04-29 PH PH12020550596A patent/PH12020550596A1/en unknown
- 2020-05-04 ZA ZA2020/02207A patent/ZA202002207B/en unknown
-
2023
- 2023-03-08 US US18/180,704 patent/US20230357417A1/en not_active Abandoned
- 2023-07-31 JP JP2023124386A patent/JP2023139267A/ja active Pending
-
2024
- 2024-10-02 JP JP2024173232A patent/JP2024177330A/ja active Pending
- 2024-12-03 US US18/967,173 patent/US20250154270A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021500055A5 (https=) | ||
| JP6215429B2 (ja) | Ｃｄ３８を特異的に認識する抗体とシクロホスファミドとを含有する抗腫瘍組合せ | |
| JP6130871B2 (ja) | Ｃｄ３８を特異的に認識する抗体とビンクリスチンとを含有する抗腫瘍組合せ | |
| IL274095B1 (en) | Antibodies and antibody-drug conjugates specific for cd123 and uses thereof | |
| JP2024177330A5 (https=) | ||
| TW202400137A (zh) | 喜樹鹼偶聯物 | |
| TWI436770B (zh) | 包含專一性辨識ｃｄ３８之抗體及阿糖胞苷（ｃｙｔａｒａｂｉｎｅ）之抗腫瘤組合 | |
| KR101905208B1 (ko) | Cd38을 특이적으로 인식하는 항체 및 보르테조밉을 함유하는 항종양 조합물 | |
| KR20220130160A (ko) | 에리불린 유도체의 약물 접합체, 이를 제조하기 위한 방법 및 의료분야에서 이의 용도 | |
| TWI454260B (zh) | 包含專一性辨識ｃｄ３８之抗體及黴法蘭（ｍｅｌｐｈａｌａｎ）之抗腫瘤組合 | |
| WO2021052402A1 (zh) | 一种喜树碱衍生物及其偶联物 | |
| WO2021142043A1 (en) | Anti-slc34a2 antibodies, antibody drug conjugates, and methods of use thereof | |
| JP2017186337A5 (https=) | ||
| JP2016505513A5 (https=) | ||
| JP2022547434A (ja) | 標的化デンドリマー複合体 | |
| AU2007333485A1 (en) | Methods for improving antibody production | |
| CN110575547A (zh) | 靶向于tf的抗体-药物偶联物及其制法和用途 | |
| CN110575548A (zh) | 靶向于cd73的抗体-药物偶联物及其制法和用途 | |
| WO2024145398A1 (en) | Antibody drug conjugates | |
| CN119053607B (zh) | 喜树碱类化合物及其偶联物、其制备方法和用途 | |
| JP2018528979A (ja) | クインスタチン化合物 | |
| RU2830242C1 (ru) | Лекарственный конъюгат производного эрибулина, способ его получения и его применение в медицине | |
| WO2026011073A1 (en) | Antibody drug conjugates | |
| TW202506691A (zh) | Ｓｔｉｎｇ促效劑化合物及其結合物 | |
| CN118681035A (zh) | 一类配体药物偶联物及其制备方法和用途 |